MED LIF SOC HUM MDA LI Lidong Pei A Comprehensive Analysis of Orforglipron Clinical Trials in Type 2 Diabetes (ACHIEVE Program) On April 1, 2026, the U.S. Food and Drug Administration officially approved Eli Lilly’s novel oral weight-loss drug, Founday…
